Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00670111 · ClinicalTrials.gov registry record · NA

Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction

A NA study, sponsored by Boston Scientific Corporation.

Terminated
Registry status
NA
Development phase
32
Enrollment target

NCT00670111: Clinical Trial NA study, sponsored by Boston Scientific Corporation.

NCT00670111 is a NA study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00670111, a NA study, was terminated before completion, sponsored by Boston Scientific Corporation.

TERMINATED
Registry status
NA
Development phase
32 participants
Enrollment target

Study Summary

This study will look at how pacing your heart may assist your daily activities and how you are feeling.

Primary Outcome

Randomized therapy order cross-over comparison at 1 month post-implant. Each patient evaluated for endpoint with and without RAP therapy at this time.

Interventions

  • DEVICE Insignia Plus / Ultra (Guidant/Boston Scientific)

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2008-07
Est. Completion 2011-07
Phase NA
Boston Scientific Corporation

280 total trials

Why NCT00670111 stopped before completion

NCT00670111 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Insignia Plus / Ultra (Guidant/Boston Scientific) is the first listed.

NCT00670111 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00670111 about?

NCT00670111 is a clinical study titled "Restoration of Chronotropic Competence in Heart Failure Patients With Normal Ejection Fraction". This study will look at how pacing your heart may assist your daily activities and how you are feeling.

What is the current status of trial NCT00670111?

This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2008-07. Estimated completion is 2011-07.

What interventions are being tested in trial NCT00670111?

The interventions under investigation include: Insignia Plus / Ultra (Guidant/Boston Scientific) (DEVICE).

Who is sponsoring clinical trial NCT00670111?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00670111's enrollment target sits among peer trials

32 1578th of 2000 higher than 409 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02445781 · 32 participants · Early Phase 1

    Differing Levels of Hypoglycemia

  • NCT02792270 · 32 participants · NA

    Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT

  • NCT03068910 · 32 participants · Early Phase 1

    Hyperandrogenemia and Altered Day-night LH Pulse Patterns

  • NCT03208868 · 32 participants · NA

    Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00670111, the US trial registry maintained by the National Library of Medicine. NCT00670111 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.